简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-10-08 14:56 Ferring Demonstrates Effectiveness of a Treat-to-Target Approach in Mild-to-Moderate Ulcerative Colitis in First Major Study
2024-10-08 11:51 Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta® (pertuzumab) Biosimilar Candidate HLX11
2024-09-27 14:49 Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors
2024-09-26 13:50 Medidata Extends Its Commitment to the Patient Experience with the Launch of Patient Payments
2024-09-26 10:35 Fujirebio Submits FDA Regulatory Filing for Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease
2024-09-26 09:52 Merz Aesthetics Announces the Launch of Ultherapy PRIME Platform as the Next Generation of Nonsurgical Skin Lifting Treatments
2024-09-26 09:46 PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products
2024-09-25 16:42 Rigaku Holdings Corporation: Approval of Listing on the Tokyo Stock Exchange Prime Market
2024-09-25 13:25 EADV 2024 Late Breaking News Sessions: New Galderma Data Demonstrating Nemolizumab’s Long-term Efficacy and Safety in Atopic Dermatitis and Durability in Prurigo Nodularis to Be Shared During Three Oral Presentations
2024-09-25 10:18 Aurion Biotech Launches Vyznova® (neltependocel) in Japan for the Treatment of Bullous Keratopathy of the Cornea
2024-09-24 15:27 Kenvue Drives Climate Action Strategy Forward
2024-09-23 15:46 Debiopharm Recognizes Groundbreaking Japanese Cancer Research During the 83rd Annual Meeting of the Japanese Cancer Association
2024-09-23 10:20 Neu-REFIX Beta glucan receives rare pediatric disease and orphan drug designations from the US FDA for treatment of Duchenne Muscular Dystrophy
2024-09-20 18:20 GC Aesthetics® Launches YOUTHLY™: A New Era for Breast Implants in China
2024-09-20 18:15 Neuraptive Therapeutics Announces Presentation of Phase 2 Topline Interim Results for NTX-001 at the 2024 American Society for Surgery of the Hand (ASSH) Annual Meeting
2024-09-20 07:39 Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
2024-09-20 07:35 Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships to Further Drive Health Impact in 93 Countries
2024-09-19 20:22 Takeda to Present Additional Clinical Trial Study Data Highlighting the Impact of Orexin Agonist TAK-861 on the Burden of Narcolepsy at Sleep Europe 2024
2024-09-19 14:38 SBC Medical Group Holdings and Pono Capital Two Announce Completion of Business Combination and Schedule to Begin Trading on the Nasdaq
2024-09-19 09:27 Notice of Withdrawal and Refiling of Premerger Notification and Report Form Under the HSR Act and Extension of Tender Offer to Acquire Vector Group Ltd.

Business Wire Weibo

Press Releases

Latest Releases